go back

Idecabtagene Vicleucel (Abecma), up to 460 Million Cells

California rates for HCPCS C9081

Idecabtagene vicleucel, up to 460 million autologous anti-BCMA CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $436,516 · 10th–90th $436,516$436,5160%50%100%$436,516Professionalmedian $501,187 · 10th–90th $129$630,9570%20%40%10th90th$501,187$100.0$500.0$2.0K$10.0K$50.0K$200.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Kaiser Permanente
Setting
Professional
Modifier
Global
Typical Low
$128.82
Median
$398.11
Typical High
$831.76
Lucent Health
Setting
Facility
Modifier
Global
Typical Low
$436,515.83
Median
$436,515.83
Typical High
$436,515.83
Lucent Health
Setting
Professional
Modifier
Global
Typical Low
$630,957.34
Median
$630,957.34
Typical High
$630,957.34
United
Setting
Professional
Modifier
Global
Typical Low
$501,187.23
Median
$501,187.23
Typical High
$549,540.87